Autoantibodies to activated blood coagulation factors in patients with ischemic heart disease

Yu F Gatiyatov , N N Tsybikov , P P Tereshkov

Kazan medical journal ›› 2012, Vol. 93 ›› Issue (2) : 181 -183.

PDF
Kazan medical journal ›› 2012, Vol. 93 ›› Issue (2) : 181 -183. DOI: 10.17816/KMJ2283
Theoretical and clinical medicine
research-article

Autoantibodies to activated blood coagulation factors in patients with ischemic heart disease

Author information +
History +
PDF

Abstract

Aim. To study the content of autoantibodies to activated blood coagulation factors IIa, VIIa and IXa during ischemic heart disease. Methods. The investigation of autoantibodies was performed in 31 patients (mean age 57.6±7.8 years, male to female ratio 4:1). The patients were divided into three groups: the first - patients with myocardial infarction in the acute stage (9 people), the second - patients with myocardial infarction in the subacute stage (9 people), the third - patients with stable angina (13 people). The control group included 18 practically healthy subjects comparable by age and sex. The study of the content of autoantibodies to blood coagulation factors was performed by an original immunoassay method of Tsybikova N.N. et al. Results. Established was a decrease in the content of the following autoantibodies: class M immunoglobulins to fac-tor VIIa, class G immunoglobulins - to factor VIIa, classes M and G immunoglobulins - to factor IXa in the acute phase of myocardial infarction compared with the controls, as well as a decrease in the content of class G immunoglobulins to the factor IXa in the acute stage of myocardial infarction compared with the subacute stage and stable angina. Conclusion. During ischemic heart disease a decrease in the content of autoantibodies to the activated blood coagulation factors IIa, VIIa and IXa occurs, which is presumably due to their binding with excessively formed activated coagulations factors.

Keywords

autoantibodies / blood coagulation factors / hemostasis / ischemic heart disease

Cite this article

Download citation ▾
Yu F Gatiyatov, N N Tsybikov, P P Tereshkov. Autoantibodies to activated blood coagulation factors in patients with ischemic heart disease. Kazan medical journal, 2012, 93(2): 181-183 DOI:10.17816/KMJ2283

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Гатиятов Ю.Ф., Цыбиков Н.Н. Аутоантитела к факторам свёртывания крови // Сибир. мед. ж., Иркутск. - 2011. - №4. - С. 34-38.

[2]

Кузник Б.И. Клеточные и гуморальные механизмы регуляции системы гемостаза в норме и патологии. - Чита: Экспресс-издательство, 2010. - 832 с.

[3]

Кузник Б.И., Цыбиков Н.Н. Иммунный механизм регуляции системы гемостаза: роль каталитических аутоантител - абзимов // Тромбоз, гемостаз и реолог. - 2011. - №3. - С. 3-17.

[4]

Цыбиков Н.Н., Цыбикова Е.А. Уровень мозгоспецифического белка S100 В, аутоантител к нему и цитокиновый профиль у больных алкогольным делирием // Мед. иммунол. - 2008. - №1 - С. 85-88.

[5]

Franchini M., Capra F., Nicolini N. et al. Drug-induced anti-factor VIII antibodies: A systematic review // Med. Sci. Monit. - 2007. - Vol. 13 - P. 55-61.

[6]

Nevinsky G.A., Buneva V.N. Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases // The Sci. World J. - 2010. - Vol. 10. - P. 1203-1233.

RIGHTS & PERMISSIONS

Gatiyatov Y.F., Tsybikov N.N., Tereshkov P.P.

AI Summary AI Mindmap
PDF

115

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/